Literature DB >> 3896097

Neuropharmacological profile of cholecystokinin-like peptides.

G Zetler.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3896097     DOI： 10.1111/j.1749-6632.1985.tb29940.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

Review 1.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

3.  The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.

Authors:  L Singh; M J Field; J Hughes; R Menzies; R J Oles; C A Vass; G N Woodruff
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain.

Authors:  K B Seroogy; A Mehta; J H Fallon
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

5.  Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.

Authors:  E Vasar; J Harro; A Lang; A Pôld; A Soosaar
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.

Authors:  J Harro; S S Jossan; L Oreland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.